Member Login
  1. Stocks
    2. /
  2. Canopy Growth (TSX: WEED)
    3. /

TSX:WEED (Canopy Growth)

About WEED

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Canopy Growth (TSX: WEED) Latest News

    Investing

    Young Investors: Should Canopy Growth Corp. Be in Your TFSA Retirement Portfolio?

    | Andrew Walker

    Canopy Growth Corp. (TSX:WEED) is one of Canada's most popular stocks. Is it a buy today?

    Read more »

    Investing

    The Biggest Opportunity Yet to Buy Canopy Growth Corp. Starts Now

    | Demetris Afxentiou

    Canopy Growth Corp. (TSX:WEED) remains an intriguing investment, but recent legislative victories in Canada and the U.S. will see an…

    Read more »

    Investing

    Which Red-Hot Cannabis Stock Offers the Best Value?

    | Ambrose O'Callaghan

    Shares of Aphria Inc. (TSX:APH) and Aurora Cannabis Inc. (TSX:ACB) have hit all-time highs, raising concerns over valuations.

    Read more »

    Investing

    Why Cannabis Investors Should Expect More Mergers and Acquisitions

    | David Jagielski

    Aurora Cannabis Inc.'s (TSX:ACB) recent acquisition attempt of CanniMed Therapeutics Inc. (TSX:CMED) could be a sign of things to come.

    Read more »

    Investing

    Canopy Growth Corp.: Buy the Dip?

    | Joey Frenette

    Canopy Growth Corp. (TSX:WEED) is starting to show signs of another hangover. Is it time to buy the dip?

    Read more »

    The Motley Fool
    Investing

    3 Reasons Aurora Cannabis Inc.’s Q1 Results Aren’t That Great

    | David Jagielski

    Aurora Cannabis Inc. (TSX:ACB) got a big boost in the share price after the company released its Q1 results. The problem…

    Read more »

    Investing

    Canopy Growth Corp.: Should You Buy at the Current Level?

    | Andrew Walker

    Canopy Growth Corp. (TSX:WEED) has more than doubled in the past month. Is more upside on the way?

    Read more »

    Investing

    Impaired Driving Risks Could Give the Government Second Thoughts About Legalizing Pot

    | David Jagielski

    Cannabis stocks such as Canopy Growth Corp. (TSX:WEED) are living off hype right now. Why that might not last.

    Read more »

    Investing

    Are We Seeing a Cannabis Bubble Begin to Form?

    | David Jagielski

    Canopy Growth Corp. (TSX:WEED) has seen its share price double in just three months, but is it too much of a…

    Read more »

    Investing

    2 Big Reasons Marijuana Legalization Could Still Be Delayed

    | David Jagielski

    Canopy Growth Corp. (TSX:WEED) currently has a big advantage over new entrants in the industry, but will it stay that way?

    Read more »

    caution
    Investing

    Why Investors of Canopy Growth Corp. Should Be Concerned

    | David Jagielski

    Canopy Growth Corp.'s (TSX:WEED) stock has more than doubled this year. Why it may be a bubble waiting to burst.

    Read more »

    Investing

    Canopy Growth Corp.: Is This the Best Marijuana Play?

    | Jacob Donnelly

    Canopy Growth Corp. (TSX:WEED) is definitely expensive, but all signs point to continued growth, so I would buy it.

    Read more »